80 FR 8661 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 80, Issue 32 (February 18, 2015)
Centers for Disease Control and Prevention
Federal Register Volume 80, Issue 32 (February 18, 2015)
| Page Range | 8661-8661 | |
| FR Document | 2015-03255 |
[Federal Register Volume 80, Number 32 (Wednesday, February 18, 2015)] [Notices] [Page 8661] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-03255] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Comparison and Validation of Screening Tools for Substance Use Among Pregnant Women, DP15-003, initial review. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date 9:00 a.m.-6:30 p.m., March 18, 2015 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92-463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Comparison and Validation of Screening Tools for Substance Use among Pregnant Women, DP15-003, initial review.'' Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015-03255 Filed 2-17-15; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 80, No. 32 / Wednesday, February 18, 2015 / Notices 8661
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
HUMAN SERVICES HUMAN SERVICES HUMAN SERVICES
Centers for Disease Control and Centers for Disease Control and Centers for Disease Control and
Prevention Prevention Prevention
Disease, Disability, and Injury Disease, Disability, and Injury Advisory Committee to the Director
Prevention and Control; Special Prevention and Control Special (ACD), Centers for Disease Control and
Emphasis Panel (SEP): Initial Review Emphasis Panel (SEP): Initial Review Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
The meeting announced below The meeting announced below
concerns Public Health Research on concerns Comparison and Validation of In accordance with section 10(a)(2) of
Modifiable Risk Factors for Spina Screening Tools for Substance Use the Federal Advisory Committee Act
Bifida, DD15–001, initial review. Among Pregnant Women, DP15–003, (Pub. L. 92–463), the Centers for Disease
In accordance with section 10(a)(2) of initial review. Control and Prevention (CDC)
the Federal Advisory Committee Act In accordance with section 10(a)(2) of announces the following meeting of the
(Pub. L. 92–463), the Centers for Disease the Federal Advisory Committee Act aforementioned subcommittee:
Control and Prevention (CDC) (Pub. L. 92–463), the Centers for Disease Time and Date: 3:30 p.m.—5:00 p.m.
announces the aforementioned meeting: Control and Prevention (CDC) EDT, March 13, 2015.
Time and Date: 10:00 a.m.–6:00 p.m., announces the aforementioned meeting: Place: This meeting will be held by
March 19, 2015 (Closed) Time and Date teleconference.
Place: Teleconference. Status: This meeting is open to the
9:00 a.m.–6:30 p.m., March 18, 2015 public, limited only by the availability
Status: The meeting will be closed to (Closed)
the public in accordance with of telephone ports. The public is
provisions set forth in section 552b(c) Place: Teleconference. welcome to participate during the
(4) and (6), title 5 U.S.C., and the public comment, which is tentatively
Status: The meeting will be closed to
Determination of the Director, scheduled from 4:45 p.m. to 4:55 p.m.
the public in accordance with
Management Analysis and Services To participate on the teleconference,
provisions set forth in section 552b(c)
Office, CDC, pursuant to Pub. L. 92–463. please dial (888) 233–0592 and enter
(4) and (6), title 5 U.S.C., and the
code 33288611.
Matters for Discussion: The meeting Determination of the Director,
will include the initial review, Management Analysis and Services Purpose: The Subcommittee will
discussion, and evaluation of Office, CDC, pursuant to Pub. L. 92–463. provide advice to the CDC Director
applications received in response to through the ACD on strategies and
Matters for Discussion: The meeting
‘‘Public Health Research on Modifiable future needs and challenges faced by
will include the initial review,
Risk Factors for Spina Bifida, DD15– State, Tribal, Local and Territorial
discussion, and evaluation of
001, initial review.’’ health agencies, and will provide
applications received in response to
guidance on opportunities for CDC.
Contact Person for More Information: ‘‘Comparison and Validation of
M. Chris Langub, Ph.D., Scientific Screening Tools for Substance Use Matters for Discussion: The STLT
Review Officer, CDC, 4770 Buford among Pregnant Women, DP15–003, Subcommittee members will discuss
Highway NE., Mailstop F–80, Atlanta, initial review.’’ progress on implementation of ACD-
Georgia 30341, Telephone: (770) 488– adopted recommendations related to
Contact Person for More Information:
3585, EEO6@cdc.gov. Public Health Surveillance, Public
M. Chris Langub, Ph.D., Scientific
Health Finance and Social Determinants
The Director, Management Analysis Review Officer, CDC, 4770 Buford
of Health as they relate to STLT public
and Services Office, has been delegated Highway NE., Mailstop F–80, Atlanta,
health agencies.
the authority to sign Federal Register Georgia 30341, Telephone: (770) 488–
notices pertaining to announcements of 3585, EEO6@cdc.gov. The agenda is subject to change as
meetings and other committee priorities dictate.
The Director, Management Analysis
management activities, for both the and Services Office, has been delegated Contact Person for More Information:
Centers for Disease Control and the authority to sign Federal Register Judith Monroe, M.D., Designated
Prevention and the Agency for Toxic notices pertaining to announcements of Federal Officer, State, Tribal, Local and
Substances and Disease Registry. meetings and other committee Territorial Subcommittee, Advisory
management activities, for both the Committee to the Director, CDC, 1600
Elaine L. Baker,
Centers for Disease Control and Clifton Road NE., M/S E–70, Atlanta,
Director, Management Analysis and Services Georgia 30333, Telephone (404) 498–
Office, Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry. 0300, Email: OSTLTSDirector@cdc.gov.
Prevention.
[FR Doc. 2015–03254 Filed 2–17–15; 8:45 am] The Director, Management Analysis
Elaine L. Baker,
emcdonald on DSK67QTVN1PROD with NOTICES
BILLING CODE 4163–18–P
and Services Office, has been delegated
Director, Management Analysis and Services the authority to sign Federal Register
Office, Centers for Disease Control and
notices pertaining to announcements of
Prevention.
meetings and other committee
[FR Doc. 2015–03255 Filed 2–17–15; 8:45 am]
management activities, for both the
BILLING CODE 4163–18–P
Centers for Disease Control and
VerDate Sep<11>2014 19:32 Feb 17, 2015 Jkt 235001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\18FEN1.SGM 18FEN1](https://thefederalregister.org/doc/80_FR_8693/page/1.svg)
Document Created: 2018-02-16 11:10:45
Document Modified: 2018-02-16 11:10:45
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 80 FR 8661 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR